Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease

被引:8
|
作者
Rahimpour, Zahra [1 ]
Hoseini, Rastegar [1 ]
Behpour, Nasser [1 ]
机构
[1] Razi Univ, Fac Sport Sci, Dept Exercise Physiol, Kermanshah, Iran
关键词
NAFLD; Exercise; Vitamin D; Liver enzymes; Lipid profile; INSULIN-RESISTANCE; MUSCLE DAMAGE; MITOCHONDRIAL; EXPRESSION; CALCIUM; OBESITY;
D O I
10.1186/s12876-022-02457-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Eccentric exhaustive exercise (EEE) training has been known as a promising training modality to enhance performance and stimulate adaptation in healthy individuals or patients that might also cause abnormal liver enzymes and lipid profiles. Vitamin D (Vit D) supplementation is believed to improve the condition of Non-Alcoholic Fatty Liver Disease (NAFLD) patients. However, there is limited evidence on the effect of Vit D supplementation on the EEE-induced alterations. This study aimed to investigate the effect of short-term supplementation of Vit D on the liver enzymes and lipid profile alterations following EEE in overweight women with NAFLD. Methods In this clinical trial, 22 overweight women with NAFLD were randomly divided into experimental and control (n = 11 in each). The experimental group consumed 2000 IU of Vit D per day for six weeks; the control group consumed a lactose placebo daily with the same color, shape, and warmth percentage. Two treadmill EEE sessions were performed before and after the six-week Vit D supplementation. Blood was taken from the antecubital vein to measure the liver enzymes, lipid profile, and Vit D at four stages: Pre 1(before the first EEE session), Post 1(after the first EEE session), Pre 2 (before the second EEE session), and Post 2 (after the second EEE session). Results The results indicate that Vit D supplementation significantly reduced Bodyweight (BW; P = 0.047), Body Mass Index (BMI; P = 0.044), Body Fat Percentage (BFP; P = 0.001), and Waist Hip Ratio (WHR; P = 0.001) in the experimental group. Additionally, the results showed increased liver enzymes (ALT, AST, and GGT) and lipid profile (TC, TG, and LDL) following EEE. While the HDL levels decreased significantly after EEE. Compared with control, the results of the independent t-test showed significantly lower ALT (P = 0.001; P = 0.001), AST (P = 0.001; P = 0.001), and GGT (P = 0.001; P = 0.001); while significantly higher Vit D (P = 0.001, P = 0.001) in the experimental in both Pre 2 and Post 2; receptively. Also, significantly lower TC (P = 0.001; P = 0.001), TG (P = 0.048; P = 0.001), and LDL (P = 0.001; P = 0.001); while significantly higher HDL (P = 0.001, P = 0.001) were observed in the experimental group compared to the control in both Pre 2 and Post 2; receptively. Conclusions Vit D supplementation reduces the liver enzymes and improves lipid profile alterations following EEE in overweight women with NAFLD. Thus, Vit D supplementation can be considered a functional supplement to improve the EEE-induced alteration. Trial registration: The trial was in the Iranian Clinical Trial Registration Center under the (IRCT20201130049538N1) on 05/07/2021.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] A randomized controlled trial of kalmegh supplementation on non-alcoholic fatty liver disease
    Nandekar, Sanket
    Kumar, Sunil
    Yadav, Devesh
    Sen, Binay
    Gadge, Pournima
    JOURNAL OF HEPATOLOGY, 2023, 78 : S830 - S830
  • [22] Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes
    Ya-ping Hao
    Xiao-jing Ma
    Yu-qi Luo
    Jie Ni
    Jian-xin Dou
    Ya-qin Hu
    Jia-an Zhu
    Yu-qian Bao
    Wei-ping Jia
    Acta Pharmacologica Sinica, 2014, 35 : 1150 - 1156
  • [23] Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes
    Hao, Ya-ping
    Ma, Xiao-jing
    Luo, Yu-qi
    Ni, Jie
    Dou, Jian-xin
    Hu, Ya-qin
    Zhu, Jia-an
    Bao, Yu-qian
    Jia, Wei-ping
    ACTA PHARMACOLOGICA SINICA, 2014, 35 (09) : 1150 - 1156
  • [24] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children
    Kodhelaj, K.
    Resuli, B.
    Petrela, E.
    Malaj, V.
    Jaze, H.
    MINERVA PEDIATRICA, 2014, 66 (01) : 23 - 30
  • [25] Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials
    Sharifi, Nasrin
    Amani, Reza
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2019, 59 (04) : 693 - 703
  • [26] Non-Alcoholic Fatty Liver Disease in Children with Overweight and Obesity
    Sasidharan Pillai, Sabitha
    Madhava, Vijayakumar
    Balakrishnan, Ajitha
    INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (8): : 863 - 863
  • [27] Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial
    Sangouni, Abbas Ali
    Azar, Mohammad Reza Mohammad Hosseini
    Alizadeh, Mohammad
    BRITISH JOURNAL OF NUTRITION, 2020, 124 (04) : 450 - 456
  • [28] The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial
    Hamid Reza Talari
    Mohamad Reza Molaqanbari
    Milad Mokfi
    Mohsen Taghizadeh
    Fereshteh Bahmani
    Seyed Mohammad Hossein Tabatabaei
    Nasrin Sharifi
    Scientific Reports, 12
  • [29] The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial
    Talari, Hamid Reza
    Molaqanbari, Mohamad Reza
    Mokfi, Milad
    Taghizadeh, Mohsen
    Bahmani, Fereshteh
    Tabatabaei, Seyed Mohammad Hossein
    Sharifi, Nasrin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [30] Meta-analysis: vitamin D and non-alcoholic fatty liver disease
    Eliades, M.
    Spyrou, E.
    Agrawal, N.
    Lazo, M.
    Brancati, F. L.
    Potter, J. J.
    Koteish, A. A.
    Clark, J. M.
    Guallar, E.
    Hernaez, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (03) : 246 - 254